泰格医药涨超7% 三季度归母净利同比增长98.73%

Core Insights - Tiger Med (300347) (03347) shares rose over 7%, currently up 7.7% at HKD 46.44, with a trading volume of HKD 21.36 million [1] Financial Performance - For the first three quarters of 2025, the company reported revenue of CNY 5.026 billion, a year-on-year decrease of 0.82% [1] - The net profit attributable to shareholders for the same period was CNY 1.02 billion, reflecting a year-on-year increase of 25.45% [1] - In the third quarter alone, the company achieved revenue of CNY 1.775 billion, a year-on-year increase of 3.86% [1] - The net profit attributable to shareholders for the third quarter was CNY 637 million, showing a significant year-on-year increase of 98.73% [1]